Immunotherapy After Surgery Shows Durable Results in High-Risk Esophageal Cancer
A phase II trial found that adjuvant sintilimab monotherapy after surgery met its primary efficacy endpoint with 87.5 percent one-year ...
A phase II trial found that adjuvant sintilimab monotherapy after surgery met its primary efficacy endpoint with 87.5 percent one-year ...
A large Chinese multicenter study finds that 16.4 percent of locally advanced gastric cancer patients achieve a pathological complete response ...
A Japanese multicenter study of 584 patients has developed a nomogram integrating KRAS mutation status, tumor burden score, nodal metastasis, ...
A retrospective study of 195 colorectal cancer patients found that removing twenty or more tumor-draining lymph nodes after neoadjuvant immunotherapy ...
A Japanese study finds that two simple postoperative blood markers can identify which patients over 70 with stage III colorectal ...
A network meta-analysis of 28 randomized trials finds that internal radiation and brachytherapy approaches, including iodine-125 brachytherapy, IMRT, and iodine-131-metuximab, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine